Académique Documents
Professionnel Documents
Culture Documents
S0927-7765(15)00059-4
http://dx.doi.org/doi:10.1016/j.colsurfb.2015.01.043
COLSUB 6876
To appear in:
Received date:
Revised date:
Accepted date:
30-11-2014
9-1-2015
27-1-2015
Graphical Abstract
us
cr
ip
t
Ac
ce
pt
e
an
Page 1 of 28
Highlights
7
Multifunctional magnetic nanoparticles using a Bodipy fluorophore (BOD-MNPs) were synthesized
around 10 nm diameter.
ip
t
The results from in vitro tests are promising for the bio-imaging of cancer cells.
11
The BOD-MNPs can easily penetrate into the cell cytoplasm in the living cells with their own
12
fluorescence properties.
13
an
us
cr
10
Ac
ce
pt
e
14
Page 2 of 28
14
15
16
ip
t
17
18
a
us
23
cr
19
20
21
22
ABSTRACT
an
24
26
Uniform PEI coated magnetic Fe3O4 (PEI-Fe3O4) nanoparticles were prepared by a modified co-
27
precipitation method and then covalently conjugated with a fluorophore molecule, Bodipy-5 by
28
the DCC/DMAP coupling reaction. The covalent binding of Bodipy-5 to the PEI coated magnetic
29
Fe3O4 nanoparticles were confirmed by means of FTIR and XPS measurements. The imaging
30
ability of the Bodipy coated magnetic nanoparticles was determined on two human cancer cells,
31
A549 (human lung adenocarcinoma epithelial) and Ishikawa (endometrial adenocarcinoma), for
32
the first time. Cytotoxicity of BOD-MNPs was evaluated in both cancer cells and healthy human
33
34
2,5-diphenyl tetrazolium bromide) assay. In vitro activities of the nanoparticles were also
35
investigated.
Ac
ce
pt
e
25
36
37
38
nanoparticles
39
40
41
Page 3 of 28
42
1. Introduction
43
In the last decade, magnetic nanostructures have become a focus of many researches at
45
46
[1], magnetically targeted drug delivery[2], hyperthermia [3], magnetic resonance imaging [4],
47
magnetofection [5] etc. These kind of nanostructures can be easily designed based on metallic,
48
bimetallic, and iron oxide nanoparticles possessing magnetic property [6,7]. Especially the
49
superparamagnetic iron oxide nanoparticles (SPIONs) have been widely applied to many area
50
due to their inoffensive toxicity profile [8,9] and easily functionalizing property with small
51
molecules and other nanostructures, which may open up many application possibilities. The
52
SPIONs may also be functionalized with drugs, fluorescent dye molecules, various hydrophilic
53
and hydrophobic coating agents such as poly(ethyleneglycol) (PEG) [10], dextran [11],
54
polyvinylpyrrolidone (PVP) [12], polyethylenimine (PEI) [13] fatty acids [14], polyvinyl alcohol
55
(PVA) [15], polyacrylic acid [16]. Among the functionalizing entities, it is well-known that
56
especially fluorescent dyes such as DAPI Hoescht, Mitotracker, Alexa Fluor, Allophycocyanin
57
are commonly used for biological labelling and staining. Nowadays multifunctional nanoparticles
58
having magnetic and fluorescence properties are of considerable interest. Recent works on the
59
60
imaging, bio-and chemo-sensing, drug delivery and therapy systems [17]. However, the problems
61
such as the quenching of the fluorophor, the depletion of magnetization and the surface chemistry
62
to cellular uptake are required to achieve for the further applications. Several synthesis strategies
63
have been reported to overcome the challenges. For example, Gun`ko and co-workers prepared
64
65
66
bonding of porphyrin to magnetic nanoparticles via an appropriate spacer. They observed that the
67
Ac
ce
pt
e
an
us
cr
ip
t
44
68
69
Recently, a new class of fluorescent dye molecules, i.e. the boron-dipyrromethene (Bodipy)
70
dyes, have been received a considerable attention. These classes of fluorescent molecules exhibit
71
a small Stokes shift, high fluorescence quantum yields, sharp excitation-emission peaks and good
72
photochemical stability. Due to their unique photophysical properties, Bodipy dyes are of
Page 4 of 28
considerable interest for potential applications such as bioimaging, sensor applications [19]. Jung
74
and co-workers [20] reported a Pb+2 sensor based on Bodipy receptor attached covalently to the
75
76
prepared by encapsulation of Fe3O4 nanocrystals within silica shells via microemulsion method.
77
Then, Bodipy fluorophore having triethoxysilane functional groups was covalently attached on
78
the surface of Fe3O4@SiO2 nanoparticles by sol-gel method. Reiser and co-workers [21] reported
79
80
on the surface of the carbon-coated cobalt nanoparticles. They functionalized covalently Bodipy
81
dye on the carbon-coated cobalt nanoparticles via click chemistry. Their photophysical
82
measurements on the Bodipy conjugated nanostructures via covalent bonding and noncovalent
83
an
84
us
cr
ip
t
73
86
containing a fluorescent Bodipy dye, and a detailed investigation of their bio-imaging and bio-
87
labelling ability on the living cells. The synthesis of new Bodipy-magnetic iron oxide
88
89
functional group on the PEI coated iron oxide nanoparticles by means of the DCC/DMAP
90
coupling reaction. The structural, morphological and optical properties of these nanocomposites
91
as well as bio-imaging ability were discussed in detail. The imaging ability of the Bodipy
92
conjugated magnetic nanocomposites (BOD-MNPs) was evaluated on two human cancer cells,
93
94
95
was tested on the healthy human umbilicial vein endothelial cell line (HUVEC) as well as the
96
97
bromide) assay. Fluoresence microscopy upon ultraviolet (UV) excitation was achieved to access
98
99
applications.
Ac
ce
pt
e
85
100
101
102
103
2.1. Materials
Page 5 of 28
p-hydroxybenzaldehyde,
104
6-bromohexanoic
acid,
benzo-18-crown-6,
3-ethyl-2,4-
106
107
polyethyleneimine (PEI), sodium hydroxide (NaOH) and other solvents (Merck) were used as
108
purchased. Purification of the BODIPY dyes was performed by flash column chromatography
109
using thickwalled glass columns and "flash grade" silica gel (Merck 230400 mesh). Purity of
110
the compounds was monitored by TLC on silica gel 60 F254s, aluminium sheets plates (Merck).
111
All commercially available reagents and reactants were obtained in reagent grade and used
112
without purification.
113
114
115
bora-3a,4a-diaza-s-indacen (5)
an
us
cr
ip
t
105
116
The
117
synthesis
of
Bodipy-5
[2,6-diethyl-1,3,5,7-tetramethyl-8-(4-(5-carboxy
119
120
hydoxybenzaldehyde (1 g, 8.18 mmol) was dissolved in dry acetonitrile (20 mL). K2CO3 (6.8 g,
121
49.08 mmol) and benzo-18-crown-6 (25 mg, 0.28 mmol) were added to the first solution. Into
122
this mixture, 6-bromohexanoic acid (2.4 g, 12.28 mmol) which dissolved in dry acetonitrile (15
123
mL) was added. The reaction mixture was refluxed for overnight. The solid part of the reaction
124
mixture was filtered off and washed for two times with cold acetonitrile (15 mL), then dissolved
125
in water (15mL) and neutralized by 4 M HCl. White precipitates were filtered and dried. As a
126
127
NMR (400 MHz, CDCl3): ppm; 9.49 (s,1H), 7.51 (d, 2H, J=8.4 Hz), 6.70 (d, 2H, J=8.4 Hz),
128
3.75 (t, 2H, J=6.3 Hz), 2.01 (t, 2H, J=7.2 Hz), 1.56-1.49 (m, 2H), 1.41-1.34 (m, 2H), 1.25-1.19
129
(m, 2H). 13C-NMR (100 MHz, CDCl3): ppm; 195.1(C=O), 176.5 (C=O), 166.0 (Ar-Cipso), 136.0
130
(Ar-C), 130 (Ar-Cipso), 118.7 (Ar-C), 72.0 (CH2), 37.8 (CH2), 32.5 (CH2), 29.4 (CH2), 28.4
131
(CH2).
Ac
ce
pt
e
118
132
133
134
(4). In an oven dried 250 mL round bottom flask, dichloromethane (DCM) (200 mL) was added
135
and bubbled under nitrogen gas for 20 min. 6-(4-formylphenoxy)hexanoic acid (3) (700 mg, 2.96
Page 6 of 28
mmol) was dissolved in this flask. Then, 3-ethyl-2,4-dimethylpyrolle (4) (729.3 mg, 5.92 mmol)
137
and trifluoroaceticacid (TFA) (three drops) were added and stirred at room temperature for
138
overnight. p-chloranil (800 mg, 3.26 mmol) was added into this reaction mixture and stirred at
139
room temperature for 5 hours. After that, triethylamine (TEA) (5 mL, 35.82 mmol) and BF3.OEt2
140
(5 mL) were added. The reaction mixture was stirred further 30 min, then extracted with the brine
141
solution (3x100 mL). Organic phase was dried over Na2SO4 then filtered and evaporated. The
142
final mixture was purified by column chromatography using CHCl3-MeOH (3%) eluent system.
1
H-NMR (400 MHz, CDCl3): ppm; 7.16 (d, 2H, J=8.6 Hz, Ar-CH), 7.00 (d, 2H, J=8.6 Hz, Ar-
cr
143
ip
t
136
CH), 4.03 (t, 2H, J=6.4 Hz, CH2), 2.56 (s, 6H, CH3), 2.44 (t, 2H, J=7.4 Hz, CH2), 2.31(q, 4H,
145
CH2) , 1.89-1.84 (m, 2H, CH2), 1.78-1.73 (m, 2H, CH2), 1.57-1.63 (m, 2H, CH2), 1.35 (s, 6H,
146
CH3) , 1.00 (t, 6H, J=6.0 Hz, CH3). 13C-NMR (100 MHz, CDCl3): ppm; 179.0 (C=O), 159.6
147
(Ar-Cipso), 155.2 (Cipso), 143.2 (Ar-Cipso), 141.9 (Cipso), 131.9 (Cipso), 129.2 (Ar-CH), 127.0 (Cipso),
148
121.1 (Cipso), 115.1 (Ar-CH), 67.7 (CH2), 33.9 (CH3), 28.9 (CH2) , 25.6 (CH2), 24.5 (CH2), 17.1
149
(CH2), 14.6 (CH2), 14.2 (CH3), 11.1 (CH3). HRMS (ESI): m/z: Calcd: 509.28650 [M-H]-. Found:
150
509.27995.
151
an
us
144
FTIR spectra were recorded on a Bruker Tensor 37 FT-IR spectrometer in KBr while a
152
C NMR
154
spectra were recorded on a Bruker Spectrospin Avance DPX400 Ultrashield spectrometer (400
155
and 100 MHz respectively) in CDCl3 and internal standard TMS. High resolution mass spectra
156
were recorded with Agilent Technologies 6224 TOF LC/MS and 6530 Accurate Mass Q-TOF
157
Ac
ce
pt
e
158
159
H and
13
153
160
161
162
the PEI concentration in the final solution is 5% (w/v). Iron(III) chloride hexahydrate
163
(FeCl3.6H2O) (2 g, 0.01 mol) and iron(II) chloride tetrahydrate (FeCl2.4H2O) (5.2 g, 0.02 mol)
164
were dissolved in this polyethyleneimine solution, respectively. The mole ratio of Fe(III)/Fe(II)
165
was kept as 2:1 while the ratio of PEI/MNP was 0.1. The solution was heated to 80 oC under
166
nitrogen atmosphere and added 50 ml of 1 M sodium hydroxide solution slow dropwise. The
Page 7 of 28
solution then was let at 80 oC for 2 h. The PEI coated magnetic Fe3O4 (PEI-Fe3O4) nanoparticles
168
separated by a centrifuge and neodymium magnet were washed many times to get rid of excess
169
polymer and base. The synthesis of the PEI-Fe3O4 nanoparticles was summarized in Scheme 1a.
170
The size and morphology of the PEI-Fe3O4 nanoparticles were determined by dynamic light
171
scattering (DLS, Malvern Zetasizer ZS) and transmission electron microscopy (TEM, FEI Tecnai
172
G2 F30 instrument) while the binding was characterized by FTIR and X-ray photoelectron
173
174
175
177
us
176
179
(10
mg,
0.02
mmol)
an
178
cr
ip
t
167
were
dissolved
in
THF
(10
mL).
N,N-
181
(0.17 mg, 1.4 mol) were added into this solution. The PEI-Fe3O4 nanoparticles (10 mg) were
182
dispersed in THF (2 mL) and added into the reaction mixture (Scheme 1b). The reaction mixture
183
was bubbled under nitrogen gas for 20 minutes then let it stirring for overnight. The obtained
184
Bodipy conjugated magnetic nanoparticles (BOD-MNPs) were collected via magnet and washed
185
Ac
ce
pt
e
180
186
187
188
189
Cytotoxicity of the BOD-MNPs was tested on three types of human cell line, A549 (Human
190
191
HUVECs (Human Umbilical Vein Endothelial Cells). A549 and HUVECs cell line were obtained
192
from ATCC (American Type Cell Collection) while Ishikawa cell line was kindly provided by
193
Dr. A. Bilir (Istanbul University, Turkey). A549 cells were grown in RPMI 1640 medium
194
containing 10% heat-inactivated fetal calf serum (FBS), 9.2% NaHCO3 and 1%
195
196
%10 FBS, %1 penicillin-streptomycin. HUVECs were incubated and grown in Nutrient Mixture
197
F12 HAM medium supplemented with 20% FBS, heparin (0.1 mg/ml), and endothelial cell
Page 8 of 28
198
growth supplement (ECGS, 0.05 mg/ml). Cells were cultured in a humidified atmosphere
199
containing 5% CO2 at 37 oC. the BOD-MNPs were dispersed in DMSO with ultrasonic bath in 15
200
201
ip
t
202
203
The cytotoxicity of the BOD-MNPs was evaluated with standard MTT (3-(4,5-
205
206
bottomed 96-multiwell plates (Techno Plastic Products AG/TPP) in 100 ml media containing
207
5x103 cells, and incubated at 37 C for 24 hours in a humidified atmosphere of 5% CO2 / 95% O2.
208
Thereafter, old medium was replaced with fresh culture media supplemented with the BOD-
209
MNPs at concentrations of 0.004, 0.008, 0.015, 0.022, 0.030, 0.037, 0.074, 0.112, 0.148 mg/ml.
210
For references, old medium was replaced with fresh medium without the dye. In order to test
211
cytotoxicity, the BOD-MNPs of each concentration were cultured with A549 and Ishikawa cells
212
for 48h and 24h, respectively. During this period after each day, the medium was aspirated and
213
100 l fresh medium containing 0.5 mg/ml MTT (Sigma) dissolved in Phosphate Buffer Saline
214
(PBS) was added to culture wells. The plates with added MTT solution were then wrapped in
215
aluminum foil and replaced in the 5% CO2 incubator for 2 hours. At the end of this period, the
216
medium was removed and the formazan crystals formed by MTT metabolism were dissolved by
217
addition of 100 l DMSO to each well. The plates were gently mixed on a plate shaker
218
approximately for 5 minutes, and their absorbance values were read at 570 nm with a microtiter
219
plate reader (Bio-Tek, ELX808IU, USA). Every test concentration had the eight replicates per
220
assay and every experiment was carried out on at least three separate occasions. The SPSS has
221
been used for the statistical analysis of assessment of the MTT assay. The data were evaluated
222
using one-way ANOVA followed by the Tukey test. A value of p<0.05 was considered as
223
significant.
Ac
ce
pt
e
an
us
cr
204
224
225
226
227
Imaging and the cell uptake study were performed by fluorescence microscope (Olympus
228
BX50 with U-UHK fluorescence attachment microscope). The cells were seeded on 12-well
Page 9 of 28
plates at concentration of 7x104 cells per well for 24 h and then incubated for 2 h in a media
230
containing 10% FBS and the BOD-MNPs without phenol red. Images were acquired immediately
231
on live cells by fluorescence microscope. A test experiment was also design with JC-1 dye
232
(common fluorescence dye) under the same conditions to compare the imaging ability of the
233
ip
t
229
234
236
us
237
cr
235
238
Uniform PEI coated magnetic Fe3O4 (PEI-Fe3O4) nanoparticles with narrow size
240
241
magnetic nanoparticles have been synthesized in aqueous PEI solution [24] (Scheme 1a).
Ac
ce
pt
e
an
239
242
Scheme 1. Synthesis route of the PEI-Fe3O4 (a) and the BOD-MNP nanoparticles (b).
243
244
245
246
about 10 nm. The size distribution of the nanoparticles was also confirmed by DLS
247
measurements. The results are also good agreement with TEM results (Fig. 1E) within
248
experimental limits even though the determined mean hydrodynamic diameter of nanoparticles is
249
around 21 nm. The size distribution of the BOD-MNPs was also determined whether or/not
10
Page 10 of 28
251
results seen in Fig. S3, it was observed that the mean hydrodynamic diameter of nanoparticles
252
253
of Bodipy-5. The lattice fringes of magnetic Fe3O4 nanoparticles in Fig. 1B and the electron
254
diffraction (SAED) pattern in a selected area in Fig. 1D also indicates to be the crystalline form
255
256
Ac
ce
pt
e
an
us
cr
ip
t
250
257
258
Fig. 1. HR-TEM images and EDS spectrum of magnetic Fe3O4 nanoparticles (A,B,C: TEM
259
images, E:Size distribution based on hydrodynamic radius (nm) from DLS, F:EF-
260
11
Page 11 of 28
261
The phase and composition of Fe3O4 nanoparticles were also determined by X-ray
262
diffraction (XRD). The diffraction pattern is consistent with the standard diffraction data of the
263
cubic structure of Fe3O4 (JCPDS file No. 19-0629) [25]. These peaks, indexed to the reflections
264
of (220), (311), (400), (511), (440) planes were compatible with XRD (Fig. 2) [26].
an
us
cr
ip
t
265
266
267
Ac
ce
pt
e
268
269
The existence of PEI on the Fe3O4 surfaces was confirmed by FTIR and XPS
270
measurements. The FTIR spectra on the PEI coated and bare Fe3O4 nanoparticles are seen
271
in Fig. 3A. A strong absorption peak at 583 cm-1 belongs to a characteristic band of the
272
Fe-O stretching vibrations of magnetic Fe3O4 nanoparticles [27]. This peak was shifted a
273
higher wavenumber of 591 cm-1 as a result of the PEI coating. Two peaks at 3400 and
274
1634 cm-1 are attributed to the stretching and bending vibrations of O-H bond from
275
residual water in the sample. A characteristic N-H stretching peak at 3381 cm-1 together
276
with bending peaks at 894, 800 and 1551 cm-1 confirms the PEI-Fe3O4 nanoparticles [28].
277
In addition, XPS spectrum confirms the existence of PEI on the magnetic nanoparticle
278
surface, Fig. 3B. The peaks correspond to the binding energies at ~711 eV and ~725 eV
279
are related to Fe 2p3/2 and Fe 2p1/2, respectively [29]. Also, the binging energy at 531 eV is
280
attributed to O1s indicating O-Fe in magnetic phase. The peak at 402 eV corresponds to
281
N1s which proves that the magnetic Fe3O4 nanoparticles covered by PEI (Fig. 3B).
12
Page 12 of 28
cr
ip
t
(A)
282
an
us
(B)
283
Fig. 3. FTIR spectra (A) of the Fe3O4 nanoparticles, the PEI-Fe3O4 nanoparticles and the
Ac
ce
pt
e
284
285
286
287
In the final step, Bodipy-5 dye was attached to PEI coated magnetic nanoparticles to
288
produce the Bodipy conjugated magnetic nanoparticles (BOD-MNPs) (Scheme 1b). After
289
covalently bonding of Bodipy-5 dye to the surface of the PEI-Fe3O4 nanoparticles, EF-
290
TEM map shows boron element (green colour) on the nanoparticles (Fig. 1D). Further
291
prove of binding the Bodipy-5 ligand to the surface of PEI-Fe3O4 is given in Fig. 3A. It is
292
clear that there are some new peaks appeared corresponding to amide group after
293
covalently bonding of Bodipy-5 dye to the surface of the PEI-Fe3O4 nanoparticles. The
294
new peaks at 1658 and 1627 cm-1 are attributed to the C=O stretching and N-H bending of
295
amide bonds, respectively, which are characteristics of CONH2 group [30, 31]. In
296
addition, the peak at 1446 cm-1 is due to the C-N stretching, and the 703 cm-1 band
297
represents the out of plane bending of the weak bond of N-H bond. These are typical
13
Page 13 of 28
298
absorption bands of amide which prove the Bodipy dye to attach covalently to the surface
299
300
302
303
absorption peak at 497 nm (S0-S1 transition) and emission peak at 506 nm in methanol
304
solution, Fig. 4A,B. Having conjugated with the magnetic nanoparticles, the absorption
305
maximum shifts to blue region, 362 nm due to the self-absorption and scattering of light
306
caused the Fe3O4 nanoparticles (Fig. 4C). However, the fluorescent properties of the
307
BOD-MNPs are almost identical with Bodipy-5 with an emission maximum at 506 nm. It
308
is obvious that the magnetic particles do not affect the emission maximum and the BOD-
309
MNPs have a good fluorescent property even although the conjugation with the magnetic
310
an
us
cr
ip
t
301
B
1
Ac
ce
pt
e
311
312
313
Fig. 4. Absorption (A, C) and emission (B, D) spectra of Bodipy-5 and the BOD-MNPs,
314
respectively. Inset pictures: the pictures of the solution of magnetic Fe3O4 nanoparticles
315
in methanol without (1) and with (2) a neodymium magnet as well as the picture of BOD-
316
14
Page 14 of 28
317
In Fig. 4, it is also seen a digital photograph of the BOD-MNPs dispersed in methanol with the
318
assistance of ultrasonic bath (Fig. 4). The nanoparticles can be easily dispersed in methanol and
319
this suspension can kept constant over a week. When a magnet placed aside, the BOD-MNPs can
320
ip
t
321
Magnetic properties of uncoated Fe3O4 nanoparticles and the BOD-MNPs were performed
322
at 25 C using a VSM in an external magnetic field ranging from -100kOe to +100 kOe, as shown
324
in Fig. 5. The saturation magnetization for the Fe3O4 NPs is 76 emu/g at 298 K, and it decreased
325
after covalently bonded to Bodipy-5 dye to 60 emu/g. According to our results, such good
326
superparamagnetism will make sure that the hybrid nanoparticles can be re-dispersed rapidly as
327
soon as the magnetic field is removed, which is highly desired for their application in
328
nanomedicine.
an
us
cr
323
Ac
ce
pt
e
329
330
331
Fig. 5. The magnetization curves at room temperature of the PEI-Fe3O4 nanoparticles (MNPs)
(line) and the BOD-MNPs (dashed line).
332
333
334
335
336
The cytotoxic effect of the BOD-MNPs was investigated on two different cancer cell
337
lines, A549 and Ishikawa cells as shown in Fig. S1. The cytotoxicity was also tested on
15
Page 15 of 28
healthy HUVECs for the comparison. As observed by MTT assay, all types of cells were
339
viable after 24 and 48 hours incubation with the BOD-MNPs in all tested concentrations.
340
It was observed that the BOD-MNPs did not have any cytotoxic effect to Ishikawa cells
341
even at higher concentrations whereas little toxicity of the nanoparticles on A549 cells and
342
HUVECs were observed at the studied concentrations, see Figs. S2 and S3. With this
343
respect, Ishikawa cells show different cellular response from A549 cells and HUVECs
344
under the studied concentrations. This small difference in cellular response may be
345
attributed to cell vision concept suggested by Mahmoudi et al. [32,33]. It has been
346
known that the uptake and defence mechanism could be different depending on the cell
347
type because of the cellular response against to same nanoparticles relate to the numerous
348
detoxification mechanisms [32,33]. Even though A549 cells and HUVECs have very little
349
toxicity, these findings show that the particles are quite suitable for further in vitro
350
imaging applications.
an
us
cr
ip
t
338
351
353
cancer cell lines, A549 and Ishikawa cells as shown in Fig. 6 and 7 by fluorescence
354
microscopy analysis. The uptake and cellular location was compared with depending the
355
cell type and the amount of the nanoparticles in the cell cultures. The pre-dispersed BOD-
356
MNPs were applied on the A549 and Ishikawa cells cultured in the appropriate method in
357
suitable concentrations, see Section 2.7. After 2h incubation, the images in Figs. 6 and 7
358
were taken immediately. It can be seen cellular uptake and cellular localization the BOD-
359
MNPs into the A549 cells in Fig. 6. The images taken with 40x and 100x magnification
360
are given together in Fig. 6. The BOD-MNPs were exhibited good cellular uptake and
361
there was no toxicity even at higher doses (0.148 mg/ml) at both 24 and 48 h exposures.
362
363
manner. By considering all applied concentrations on A549 and Ishikawa cells, the BOD-
364
MNPs were localized in the cytoplasm within the lipophilic regions of intracellular
365
organelles with evidence for uptake in the endoplasmic reticulum. Cells were exhibited a
366
bright green cell profile. The BOD-MNPs are localized near the nucleus with increasing
367
the concentration.
Ac
ce
pt
e
352
368
16
Page 16 of 28
ip
t
cr
us
an
M
d
Ac
ce
pt
e
369
370
Fig. 6. Localisation and cellular uptake of the BOD-MNPs into the A549 cells. 0.037
371
mg/ml (A), 0.074 mg/ml (B), 0.112 mg/ml (C) and 0.148 mg/ml (D) of the
372
373
374
375
It is obvious that the imaging profile is almost the same for Ishikawa cells. Therefore
376
the images taken with the magnifications are given for only 0.037 mg/ml. for the other
377
concentration, only 40x pictures are given in Fig. 7(1). For the comparison, The A549 and
378
Ishikawa cells was dyed a standard JC-1 dye at a concentration of 2.5 g/ml. Images were
17
Page 17 of 28
379
380
Ac
ce
pt
e
an
us
cr
ip
t
381
382
383
Fig. 7. (1) Localisation and cellular uptake of the BOD-MNPs into the Ishikawa cells. 0.037(A)
384
and 0.074 mg/ml (B) of the dye was treated in live Ishikawa cells for 1 h. (Scale bar: 20
385
m (A-B) and 10 m (A'-B'). (2) The images of the standard JC-1 dyed A549 and
386
387
388
389
390
391
392
18
Page 18 of 28
393
4. Conclusion
394
396
prepared by a facile method. The magnetic Fe3O4 nanoparticles coated with polyethyleneimine
397
were synthesized and then covalently conjugated a fluorophore molecule, Bodipy-5 by the
398
DCC/DMAP coupling reaction. It was found that the BOD-MNPs have no cytotoxic effect to
399
A549 and Ishikawa cells as well as HUVECs. In vitro bio-imaging results revealed that the BOD-
400
MNPs can easily penetrate into the cell cytoplasm in the living cells with their own fluorescence
401
properties. For this reason, these are potentially capable of cell imaging. In addition, their ability
402
to accumulate in cancer cells besides their superparamagnetic properties makes them a potential
403
us
cr
ip
t
395
405
an
404
Acknowledgements
406
The authors acknowledge the Akdeniz University Coordination Unit of Scientific Research
408
Projects (project No. 2012.01.0115.001) for their financial support. The authors are grateful to
409
410
laboratory facilities. The authors thank especially Mustafa Gler (UNAM, Bilkent University,
411
Ac
ce
pt
e
407
412
413
References
414
415
[1] J. Wang, Z. Zhu, A. Munir and H.S. Zhou, Talanta, 84 (2011) 783.
416
417
418
[3] C.S.S.R. Kumar and F. Mohammad, Adv. Drug Deliver Rev., 63 (2011) 789.
419
[4] A. Yilmaz, S. Rsch, K. Klingel, R. Kandolf, X. Helluy, K.H. Hiller, P.M. Jakob and U.
Sechtem, Int. J. Cardiol., 163 (2013) 175.
420
421
[5] Y. Ma, Z. Zhang, X. Wang, W. Xia and H. Gu, Int. J. Phar, 419 (2011) 247.
422
[6] C. Sun, J.S.H. Lee, M.Q. Zhang, Adv. Drug Deliver Rev., 60 (2008) 1252.
423
[7] J.R. McCarthy and R. Weissleder, Adv. Drug Deliver Rev., 60 (2008) 1241.
19
Page 19 of 28
425
426
[10] A.K. Gupta, R.R. Naregalkar, V.D. Vaidya and M. Gupta, Nanomedicine, 2 (2007) 23.
427
428
[12] H.Y. Lee, S. H. Lee, C. Xu, J. Xie, J.H. Lee, B. Wu, A.L. Koh, X. Wang, R.Sinclair, S. X.
429
430
(2008) 165101.
[13] H. Cai, X. An, J. Cui, J. Li, S. Wen, K. Li, M. Shen, L. Zheng, G. Zhang and X. Shi, ACS
Appl. Mater. Interfaces, 5 (2013) 1722.
432
us
433
cr
431
ip
t
424
coated with silica, M.Sc. thesis, Royal Institute of Technology, Stockholm, 2012.
434
[15] S. Kayal and R.V. Ramanujan, Mater. Sci. Eng., C30 (2010) 484.
436
[16] J. Fresnais, M. Yan, J. Courtois, T. Bostelmann, A. Bee and J.F. Berret, J. Colloid Interface
Sci., 395 (2013) 24.
437
438
an
435
439
[18] S.A. Corr, Y.P. Rakovich and Y.K. Gunko, Nanoscale Res. Lett., 3 (2006) 87.
441
[19] a) N. Boens, V. Leen and W. Dehaen, Chem. Soc. Rev., 41 (2012) 1130. b) S.G. Awuah and
442
Y. You, RSC. Adv., 2 (2012) 11169. c) G. Ulrich, R. Ziessel and A. Harriman, Angew.
443
Chem. Int. Ed., 47 (2008) 1184. d) Y. Cakmak, T. Nalbantoglu, T. Durgut and E.U. Akkaya,
444
Tet. Lett., 5 (2014) 538. e) S.E. Cakmak and E.U. Akkaya, Angew.Chem. Int.Ed., 52 (2013)
445
11364.
Ac
ce
pt
e
446
440
[20] H. Son, H.Y. Lee, J.M. Lim, D. Kan, W.S. Han, S.S. Lee and J.H. Jung, Chem. Eur. J., 16
(2010) 11549.
447
448
[21] Q.M. Kainz, A. Schaltz, A. Zolpfl, W. Stark and O. Reiser, Chem. Materials, 23 (2011)
3606.
449
450
451
452
453
[24] Z.J. Zhang, X.Y. Chen, B.N. Wang and C.W. Shi, J. Cryst. Growth, 310 (2008) 5453.
20
Page 20 of 28
454
[25] Joint Committee on Powder Diffraction Standards, Diffraction Data File No. 19-0629
JCPDS international center for diffraction data, Pennsylvania.
455
456
[26] S. Zhang, H. Niu, Z. Hu, Y. Cai andY. Shi, J. Chromatogr A, 1217 (2010) 4757.
457
[27] R.M. Patil, P.B. Shete, N.D. Thorat, S.V. Otari, K.C. Barick, A. Prasad, R.S. Ningthoujam,
ip
t
458
459
460
[29] J. Sun, S. Zhou, P. Hou, Y. Yang, J. Weng, X. Li and M. Li, J. Biomed. Mat. Res. A (2006)
[30] F. Mrquez, T. Campo, M. Cotto, R. Polanco, R. Roque, P. Fierro, J.M. Sanz, E. Elizalde
and C. Morant, Soft Nanoscience Letters, 1 (2011) 25.
463
us
462
cr
333.
461
[31] M.P. Calatayud, C. Riggio, V. Raffa, B. Sanz, T.E. Torres, M.R. Ibarra, C. Hoskins, A.
465
Cuschieri, L.Y. Wang, J. Pinkernelle, G. Keilhoff and G.F. Goya, J. Mater. Chem. B, 1
466
(2013) 3607.
[32] M. Mahmoudi, S. Laurent, M.A. Shokrgozar and M. Hosseinkhani, ACS Nano, 5 (2011)
7263.
468
467
an
464
470
471
(2012) 5461.
Ac
ce
pt
e
469
472
473
21
Page 21 of 28
473
Figure Captions
474
Fig. 1. HR-TEM images and EDS spectrum of magnetic Fe3O4 nanoparticles (A,B,C: TEM
476
images, E:Size distribution based on hydrodynamic radius (nm) from DLS, F:EF-TEM
477
ip
t
475
479
Fig. 3. FTIR spectra (A) of the Fe3O4 nanoparticles, the PEI-Fe3O4 nanoparticles and the BOD-
cr
478
480
Fig. 4. Absorption (A, C) and emission (B, D) spectra of Bodipy-5 and the BOD-MNPs,
482
respectively. Inset pictures: the pictures of the solution of magnetic Fe3O4 nanoparticles
483
in methanol without (1) and with (2) a neodymium magnet as well as the picture of
484
an
Fig. 5. The magnetization curves at room temperature of the PEI-Fe3O4 nanoparticles (MNPs)
485
us
481
486
Fig. 6. Localisation and cellular uptake of the BOD-MNPs into the A549 cells. 0.037 mg/ml
488
(A), 0.074 mg/ml (B), 0.112 mg/ml (C) and 0.148 mg/ml (D) of the BODIPY-
489
magnetic nanocomposite was treated in live A549 cells for 1 h. The images were
Ac
ce
pt
e
487
490
491
Fig. 7. (1) Localisation and cellular uptake of the BOD-MNPs into the Ishikawa cells. 0.037(A)
492
and 0.074 mg/ml (B) of the dye was treated in live Ishikawa cells for 1 h. (Scale bar: 20
493
m (A-B) and 10 m (A'-B'). (2) The images of the standard JC-1 dyed A549 and
494
495
496
497
498
499
22
Page 22 of 28
ip
t
cr
us
an
M
d
Ac
ce
pt
e
500
501
502
503
504
505
506
Fig. 1
507
508
509
510
23
Page 23 of 28
ip
t
cr
us
511
an
512
513
514
515
Fig. 2
516
517
Ac
ce
pt
e
518
519
520
521
522
523
524
525
526
527
528
24
Page 24 of 28
529
us
cr
ip
t
(A)
530
Ac
ce
pt
e
an
(B)
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
Fig. 3
25
Page 25 of 28
550
ip
t
an
us
cr
551
552
Fig. 4
553
Ac
ce
pt
e
554
555
556
557
Fig. 5
558
26
Page 26 of 28
ip
t
cr
us
an
M
d
Ac
ce
pt
e
559
560
561
562
563
564
565
566
Fig. 6
567
568
569
570
571
572
27
Page 27 of 28
Ac
ce
pt
e
an
us
cr
ip
t
573
574
575
576
577
578
579
580
581
582
583
Fig. 7
28
Page 28 of 28